Supreme Court Report

Supreme Court of the United States · Official docket →

Moose Jooce, et al. v. Food and Drug Administration, et al.

Paid petition · United States Court of Appeals for the District of Columbia Circuit, No. 20-5048, 20-5049, 20-5050 · judgment December 1, 2020


Certiorari denied · June 28, 2021
Pre-decision estimate: 8% cert probability (95% interval 5%–12%)

Before the decision, about 1.9× the 4.1% base rate. The model weighted this up for a D.C. Circuit decision below, a dissent in the court below (flagged in the petition), and a petition filed soon after the judgment below.

Questions presented

Whether a government official has the power to validate the unauthorized actions of other officials is presumptively determined by the law of agency, specifically the doctrine of ratification. According to that common law body of rules, a principal cannot ratify the action of an agent unless the principal had the authority to take the action both originally and at the time of ratification. Fed. Elec. Comm’n v. NRA Political Victory Fund, 513 U.S. 88, 98–99 (1994). Although this Court has never done so, the D.C. Circuit applies the doctrine of ratification to uphold government action otherwise unconstitutional under the Appointments Clause. Such ratification will be upheld even if it is a mere “rubberstamp” that does not comport with the procedural and substantive limitations normally applicable to the agency action being ratified. In developing this powerful reviewthwarting defense, the D.C. Circuit has, in contrast to the Ninth Circuit Court of Appeals, read this Court’s decision in NRA Political Victory Fund narrowly to apply only in circumstances where the limitation on a principal’s authority to ratify is time-based, as with a statute of limitations. The questions presented are:

  1. May a regulation be ratified if the Appointments Clause prohibited the purported agent’s exercise of rulemaking authority?

  2. If so, must the ratification comply with the constraints that would normally govern an officer’s rulemaking, such as the Administrative Procedure Act’s “reasoned decision-making” requirement?

Counsel of record

For petitioner
Damien Michael Schiff
Pacific Legal Foundation

For respondent
Brian H. Fletcher
Acting Solicitor General

Case

Conference history
Distributed for 1 conference

Amicus briefs
3 cert-stage

Proceedings

  1. Jun 28 2021
    Petition DENIED.
  2. Jun 08 2021
    DISTRIBUTED for Conference of 6/24/2021.
  3. Jun 08 2021
    Reply of petitioners Moose Jooce, et al. filed. (Distributed)
  4. Jun 02 2021
    Letter waiving the 14-day waiting period for the filing of a reply pursuant to Rule 15.5 filed.
  5. Jun 02 2021
    Brief of respondents Food & Drug Administration, et al. in opposition filed.
  6. Apr 02 2021
    Brief amici curiae of Senator Rand Paul, Senator Ron Johnson and Representative Jim Baird filed.
  7. Apr 01 2021
    Brief amici curiae of The Cato Institute filed.
  8. Mar 31 2021
    Brief amici curiae of 36 National and State Electronic Nicotine Delivery System Product Advocacy Associations and Representative Industry Stakeholders filed.
  9. Mar 22 2021
    Motion to extend the time to file a response is granted and the time is further extended to and including June 2, 2021.
  10. Mar 19 2021
    Motion to extend the time to file a response from May 3, 2021 to June 2, 2021, submitted to The Clerk.
  11. Mar 11 2021
    Motion to extend the time to file a response is granted and the time is extended to and including May 3, 2021.
  12. Mar 10 2021
    Motion to extend the time to file a response from April 2, 2021 to May 3, 2021, submitted to The Clerk.
  13. Mar 04 2021
    Blanket Consent filed by Petitioner, Moose Jooce, et al.
  14. Feb 26 2021
    Petition for a writ of certiorari filed. (Response due April 2, 2021)